Core Viewpoint - Zhonghong Medical (300981) is expected to report significant losses for the fiscal year 2025, primarily due to industry cycles, currency fluctuations, and asset impairments [1][3]. Trading Information Summary - On January 29, Zhonghong Medical closed at 12.95 yuan, down 1.89%, with a turnover rate of 0.99%, a trading volume of 38,800 shares, and a transaction value of 50.41 million yuan [1]. - On the same day, the main funds experienced a net outflow of 5.04 million yuan, while retail investors saw a net inflow of 4.97 million yuan [1][3]. Performance Disclosure Highlights - Zhonghong Medical forecasts its total revenue for 2025 to be between 2.097 billion yuan and 2.726 billion yuan [1]. - The company anticipates a net profit loss attributable to shareholders ranging from 87 million yuan to 130 million yuan, with a non-recurring net profit loss expected to be between 125 million yuan and 186 million yuan [1][3]. Company Announcement Summary - The 2025 annual performance forecast indicates a net profit loss of 130.5 million yuan to 87 million yuan, significantly impacted by the protective glove industry's cyclical nature, exchange rate changes, and various asset impairments totaling approximately 27 million yuan to 41 million yuan for fixed assets and inventory, and 58 million yuan to 88 million yuan for goodwill [1][3].
股市必读：中红医疗（300981）预计2025年全年营业收入20.97亿元至27.26亿元